NEUROBIOLOGY OF DISEASE

Scope & Guideline

Exploring the Frontiers of Neurobiology and Disease

Introduction

Immerse yourself in the scholarly insights of NEUROBIOLOGY OF DISEASE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0969-9961
PublisherACADEMIC PRESS INC ELSEVIER SCIENCE
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 1994 to 2024
AbbreviationNEUROBIOL DIS / Neurobiol. Dis.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address525 B ST, STE 1900, SAN DIEGO, CA 92101-4495

Aims and Scopes

The journal 'Neurobiology of Disease' aims to advance the understanding of neurological disorders through a multidisciplinary approach that encompasses molecular, cellular, and systemic studies of the nervous system. The journal publishes research that explores the underlying mechanisms of various diseases affecting the nervous system, including but not limited to neurodegenerative diseases, neuroinflammation, and the interplay between genetic and environmental factors.
  1. Molecular Mechanisms of Neurodegeneration:
    The journal focuses on elucidating the molecular pathways involved in neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's disease. This includes studies on protein misfolding, aggregation, and the role of genetic mutations.
  2. Neuroinflammation:
    Research addressing the role of neuroinflammatory processes in various neurological disorders is a core area of focus. This includes the contribution of microglia and astrocytes to neuronal health and disease.
  3. Neurodevelopment and Plasticity:
    The journal publishes studies investigating neurodevelopmental disorders, synaptic plasticity, and the mechanisms by which neural circuits adapt in response to injury or disease.
  4. Gut-Brain Axis:
    Emerging research on the gut-brain axis highlights the influence of gut microbiota on brain health and disease, with implications for understanding conditions like Alzheimer's and autism spectrum disorders.
  5. Neurovascular Interactions:
    The interplay between the nervous system and vascular health is a significant theme, including studies on the blood-brain barrier, neurovascular coupling, and their roles in diseases like stroke and multiple sclerosis.
Recent years have seen the emergence of several key themes within the 'Neurobiology of Disease', reflecting the evolving landscape of neuroscience research and the integration of new methodologies and interdisciplinary approaches.
  1. Precision Medicine in Neurology:
    There is an increasing focus on precision medicine, utilizing genetic and molecular profiling to tailor interventions for individual patients, particularly in neurodegenerative diseases.
  2. Biomarkers and Diagnostics:
    The identification and validation of biomarkers for early diagnosis and prognosis of neurological disorders are gaining attention, with significant research dedicated to blood and cerebrospinal fluid biomarkers.
  3. Neuroimmune Interactions:
    The exploration of the immune system's role in neurological diseases, including the effects of neuroinflammation and the potential for immunotherapy, is becoming a prominent area of study.
  4. Neurotechnology and Neuroengineering:
    Advancements in neurotechnology, including optogenetics, neuroimaging, and bioengineering approaches, are increasingly featured, reflecting a trend towards innovative therapeutic strategies.
  5. Microbiome Research:
    The gut-brain axis and the role of the microbiome in neurological health and disease are emerging as critical topics, highlighting the interconnectedness of systemic health and brain function.

Declining or Waning

While 'Neurobiology of Disease' continues to explore a diverse range of topics, certain areas have seen a decline in prominence in recent publications. This could be due to shifts in research focus, advances in technology, or the emergence of new interdisciplinary fields.
  1. Traditional Neuropharmacology:
    Research focused solely on traditional pharmacological approaches to treat neurological disorders is less prominent as the field increasingly shifts towards personalized and systems biology approaches.
  2. Single Disease Focus Studies:
    There is a noticeable decline in studies that focus narrowly on a single disease without considering comorbidities or the broader context of neurodegeneration.
  3. Behavioral Studies in Isolation:
    The emphasis on behavioral studies conducted in isolation, without integrating molecular or genetic insights, appears to be waning, as the field moves towards more comprehensive, multi-dimensional approaches.

Similar Journals

MOLECULAR AND CELLULAR NEUROSCIENCE

Charting New Territories in Molecular Neuroscience
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 1044-7431Frequency: 8 issues/year

MOLECULAR AND CELLULAR NEUROSCIENCE, published by Academic Press Inc Elsevier Science, is a pivotal journal dedicated to the expansive fields of Cellular and Molecular Neuroscience, providing a platform for the dissemination of innovative research and theoretical advancements since its establishment in 1990. With an ISSN of 1044-7431 and a commitment to high scholarly standards, this journal holds a notable Q2 ranking in key categories such as Cell Biology and Molecular Biology, highlighting its significant impact within the academic community. Although currently not an Open Access journal, it offers a wealth of insightful contributions aimed at fostering understanding and collaboration among researchers, professionals, and students. The journal's ongoing publication trajectory through to 2024 guarantees a continuous flow of cutting-edge research that is critical for addressing complex questions in neuroscience. As it plays a crucial role in advancing our understanding of molecular mechanisms underpinning neural function and pathology, MOLECULAR AND CELLULAR NEUROSCIENCE remains an essential reference for anyone invested in these dynamic fields.

Frontiers in Neuroscience

Connecting diverse fields through rigorous research.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Neuroscience, published by FRONTIERS MEDIA SA, is a premier open-access journal dedicated to advancing our understanding of the nervous system through innovative and rigorous research. Since its inception in 2007, this journal has become an influential platform for researchers, featuring a diverse range of topics across various subfields of neuroscience. With its current ranking in the second quartile (Q2) of the category "Neuroscience (miscellaneous)" and a commendable position of #40 out of 113 in general neuroscience according to Scopus, Frontiers in Neuroscience is recognized for its high-impact contributions. The journal promotes free access to scholarly work, ensuring that cutting-edge neuroscience studies reach a global audience and foster collaboration across disciplines. By bridging gaps in knowledge and facilitating the exchange of ideas, Frontiers in Neuroscience plays a pivotal role in addressing the complexities of the nervous system and its effects on behavior, cognition, and health.

Frontiers in Molecular Neuroscience

Connecting researchers to shape the future of molecular neuroscience.
Publisher: FRONTIERS MEDIA SAISSN: 1662-5099Frequency: 1 issue/year

Frontiers in Molecular Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the molecular mechanisms underlying neurological functions and disorders. Since its inception in 2008, the journal has established itself as a reputable source of cutting-edge research, earning a respectable Q2 ranking in both the fields of Cellular and Molecular Neuroscience and Molecular Biology as of 2023. With an ongoing commitment to fostering innovation, the journal presents a platform for researchers, professionals, and students to disseminate their findings and engage in scholarly discourse. The E-ISSN 1662-5099 ensures that research is readily accessible, facilitating the exchange of knowledge crucial to tackling the complexities of neurological conditions. Situated in Switzerland, the journal’s global reach is augmented by its open-access model, allowing for wide dissemination of critical research findings to a diverse audience. Join the vibrant community of scientists and practitioners who are shaping the future of molecular neuroscience through their contributions to this dynamic journal.

METABOLIC BRAIN DISEASE

Connecting disciplines to combat brain disease.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0885-7490Frequency: 6 issues/year

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.

Science Bulletin

Bridging gaps, fostering innovation.
Publisher: ELSEVIERISSN: 2095-9273Frequency: 24 issues/year

Science Bulletin is a premier multidisciplinary journal published by Elsevier, renowned for its commitment to advancing scientific knowledge across various fields. With an impressive impact factor and achieving a distinguished Q1 category ranking in 2023 within its multidisciplinary scope, Science Bulletin stands out for its rigorous peer-review process and high-quality research dissemination. Since its inception in 2015, the journal has been pivotal in bridging gaps between diverse scientific disciplines, fostering collaboration and innovation. Researchers and professionals can benefit from its Open Access options, ensuring wider visibility and accessibility of groundbreaking research. With a Scopus rank of #4 out of 171, placing it in the 97th percentile, Science Bulletin continues to set the standard for scholarly excellence, making it an essential resource for those seeking to stay at the forefront of scientific discovery.

Eneurobiologia

Exploring Neural Complexities, One Study at a Time
Publisher: UNIV VERACRUZANA, INST INVESTIGACIONES & EDUCACIONISSN: 2007-3054Frequency: 2 issues/year

Eneurobiologia is an esteemed open-access journal published by UNIV VERACRUZANA, INST INVESTIGACIONES & EDUCACION, dedicated to advancing research in the vibrant field of neurobiology. With its launch in 2010, the journal aims to disseminate high-quality, peer-reviewed research articles that explore the complexities of neural systems, neurodevelopment, and neurodegenerative disorders. By providing a platform for both established researchers and emerging scholars, Eneurobiologia fosters interdisciplinary collaboration and knowledge exchange within the scientific community. Its open-access model ensures that valuable findings are accessible to a global audience, promoting the widespread application of neurobiological research. As a crucial resource for students, professionals, and researchers alike, Eneurobiologia plays a pivotal role in shaping the future of neurobiological studies and enhancing our understanding of the brain and nervous system.

SYNAPSE

Illuminating Synaptic Mechanisms, Inspiring Discovery
Publisher: WILEYISSN: 0887-4476Frequency: 12 issues/year

SYNAPSE, an esteemed journal in the field of Cellular and Molecular Neuroscience, is published by Wiley and serves as a vital platform for disseminating groundbreaking research in neuroscience. Established in 1987, this journal has been pivotal in exploring the intricate mechanisms governing synaptic function and neural communication, contributing to our understanding of the nervous system. With an ISSN of 0887-4476 and an E-ISSN of 1098-2396, SYNAPSE is indexed in Scopus and currently holds a Q4 quartile ranking in its category, reflecting its niche yet significant presence within the research community. Despite its recent ranking in the 21st percentile among its peers, the journal’s commitment to quality and innovation remains unwavering. It is published from Hoboken, New Jersey, and although it is not an open-access journal, it provides invaluable insights and critical reviews that are pivotal for researchers, professionals, and students alike who seek to advance their knowledge in the dynamic field of neuroscience. Join us in contributing to the ever-evolving discourse in cellular and molecular neuroscience through SYNAPSE.

Translational Neurodegeneration

Fostering Excellence in Neuroscience Research
Publisher: BMCISSN: 2047-9158Frequency: 1 issue/year

Translational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.

Frontiers in Cellular Neuroscience

Pioneering open-access research in cellular neuroscience.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Cellular Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal operating out of Switzerland that has been at the forefront of disseminating cutting-edge research since its inception in 2007. With a focus on the cellular and molecular aspects of neuroscience, this journal addresses fundamental questions and advances our understanding of the nervous system, making it indispensable for researchers, professionals, and students in the field. As of 2023, it is ranked in the Q2 category for Cellular and Molecular Neuroscience, positioned at rank #27 out of 97 in Scopus, and boasting a notable 72nd percentile ranking, reflecting its impactful contributions to the discipline. The journal's commitment to open access enhances the accessibility of vital research findings, promoting knowledge sharing and collaboration. Researchers looking for a platform to publish groundbreaking neuroscience research will find Frontiers in Cellular Neuroscience an ideal venue for reaching a wide audience.

Molecular Brain

Unraveling the Mysteries of Neural Function at the Molecular Level
Publisher: BMCISSN: Frequency: 1 issue/year

Molecular Brain is a prestigious open-access journal published by BMC, dedicated to advancing the field of neuroscience with a particular focus on cellular and molecular mechanisms. Since its inception in 2008, the journal has been committed to disseminating high-quality research that explores the intricate workings of the brain, particularly in areas related to cellular and molecular neuroscience. Located in the heart of London, England, Molecular Brain has garnered significant recognition in the academic community, boasting a 2023 categorization in the Q2 quartile for both Cellular and Molecular Neuroscience and Molecular Biology, reflecting its growing influence and relevance in these fields. With its Scopus ranks placing it in the top 32% and 38% of its respective categories, the journal serves as an essential platform for researchers, professionals, and students alike, encouraging collaboration and knowledge-sharing through its accessible online format.